|
Volumn 7, Issue 6, 2000, Pages 420-425
|
Cost-effectiveness analysis and the selection of blood products
a
HOSPITAL CLÍNIC
(Spain)
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BLOOD COMPONENT;
BLOOD COMPONENT THERAPY;
BLOOD DONOR;
BLOOD TRANSFUSION;
COST BENEFIT ANALYSIS;
COST EFFECTIVENESS ANALYSIS;
DRUG SAFETY;
HEALTH CARE FINANCING;
HEALTH CARE SYSTEM;
INFECTION;
LEUKOPENIA;
PRIORITY JOURNAL;
REVIEW;
TORQUE TENO VIRUS;
VIRUS INACTIVATION;
BLOOD COMPONENT REMOVAL;
BLOOD TRANSFUSION;
CONSUMER PRODUCT SAFETY;
COST-BENEFIT ANALYSIS;
HUMANS;
|
EID: 0033788984
PISSN: 10656251
EISSN: None
Source Type: Journal
DOI: 10.1097/00062752-200011000-00017 Document Type: Review |
Times cited : (10)
|
References (41)
|